| CODE |
99706 |
| COMPONENT |
HEPATOCELLULAR CARCINOMA SCREENING |
| CHECK DIGIT |
4 |
| PROPERTY |
IMPRESSION/INTERPRETATION OF STUDY |
| DATE LAST CHANGED |
2022-02-16 00:00:00 |
| CHANGE TYPE |
ADD |
| TIME ASPECT |
POINT |
| SYSTEM |
~PATIENT |
| SCALE TYPE |
Ordinal |
| METHOD TYPE |
BASED ON CLINICAL+LAB DATA |
| CLASS |
MOLPATH |
| FULLY SPECIFIED NAME |
HEPATOCELLULAR CARCINOMA SCREENING:IMP:PT:~PATIENT:ORD:BASED ON CLINICAL+LAB DATA |
| SHORTNAME |
HCC SCREEN CLIN+LAB DATA - IMP |
| LONG COMMON NAME |
HEPATOCELLULAR CARCINOMA SCREENING [INTERPRETATION] BASED ON CLINICAL AND LAB DATA |
| COMMENTS |
The overall hepatocellular carcinoma (HCC) screening result for an at-risk patie
nt based on lab and clinical data, such as the patient's biological sex and mult
iple biomarkers. The biomarkers may include alpha-fetoprotein (AFP) levels and t
he detection of targeted methylated cell-free DNA (cfDNA) associated with HCC. E
xamples of methylation targets include the HOXA1 and TSPYL5 gene. A positive tes
t result suggests the presence of HCC, and clinical correlation is suggested. A
negative test result indicates a lower likelihood of the presence of HCC. [PMID
: 32889146]
|
| MASTER ENTRY FOR VUID |
YES |
| VUID |
5342390 |
| EFFECTIVE DATE/TIME |
-
- 2022-04-11 00:00:00
- STATUS: ACTIVE
|
